• A 1-Year-Old Child with Peripheral T-cell Lymphoma of the Orbit
• A brisk peripheral T-cell reaction following rituximab treatment for follicular lymphoma
• A case of t-cell lymphoblastic lymphoma characterized by pleural effusion combined with pericardial effusion
• A Novel JAK2 Fusion in T-Cell Prolymphocytic Leukemia
• A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer/T-cell lymphoma patients
• A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors
• Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug Design
• Anaplastic Large Cell Lymphoma Growing in the Pacemaker Pocket
• Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial
• Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides
• Applications of cell therapy in the treatment of virus-associated cancers
• Aspirin Inhibits Colorectal Cancer via the TIGIT-BCL2-BAX pathway in T Cells
• Atypical Cutaneous Manifestation of Mycosis Fungoides: A Case Report
• Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma
• Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma
• Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
• Bullous mycosis fungoides-clinical indicator for an aggressive course of disease
• Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence
• Case report: Suspicious laryngeal mass: a case of laryngeal lymphoma misdiagnosed as chronic inflammation
• CD19 CAR T cells for B cell malignancies: a systematic review and meta-analysis focused on clinical impacts of CAR structural domains, manufacturing conditions, cellular product, doses, patient's age, and tumor types
• Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data
• Clinical features and prognostic analysis of colorectal extranodal NK/T cell lymphoma
• Clinical Impact of Microbiome Characteristics in Treatment-Naive Extranodal NK/T-Cell Lymphoma Patients
• Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature
• Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma
• Concomitant cutaneous T-cell lymphoma and biclonal B-cell lymphoproliferative disorder
• Concurrent papular and dyshidrotic mycosis fungoides: A case report in a patient with skin of color
• Current and future therapies for follicular lymphoma
• Cutaneous Anaplastic T-Cell Lymphoma Mimicking a Small Abscess: A Case Report
• Cutaneous T cell Lymphoma in Skin of Color: A Review
• Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study
• Dermatoscopy and Histology of Primary Cutaneous Aggressive Epidermotropic CD8+ T-Cell Lymphoma
• Dermoscopic features of primary cutaneous extranodal natural killer (NK)/T-cell lymphoma
• Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
• Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T-cell lymphoma, NOS in a leukemic phase?
• EBV + B cell-derived exosomes promote EBV-associated T/NK-cell lymphoproliferative disease immune evasion by STAT3/IL-10/PD-L1 pathway
• Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals
• Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse
• Exploring the dynamics of Programmed Death-Ligand 1 in canine lymphoma: unraveling mRNA amount, surface membrane expression and plasmatic levels
• Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
• Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy
• Gamma-delta T-cell large granular lymphocytic leukemia in the setting of rheumatologic diseases
• GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma
• H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma
• Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors
• Hemophagocytic syndrome secondary to invasive NK cell leukemia and T-cell lymphoma treated with the modified MINE protocol: report of three cases and literature review
• Histone deacetylase inhibitor and PD-1 blockade synergistically inhibit B-cell lymphoma progression in mice model by promoting T-cell infiltration and apoptosis
• Hypopyon as the first presentation of Extranodal natural killer/T-cell lymphoma, nasal type
• Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
• Immunoglobulin class-switch recombination: Mechanism, regulation, and related diseases
• Intestinal Perforation in a Case of Peripheral T Cell Lymphoma after Initiation of Chemotherapy
• Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
• Intradermal vaccination with a phytoglycogen nanoparticle and STING agonist induces cytotoxic T lymphocyte-mediated antitumor immunity
• Investigation of the mutations in the genes involved in Janus kinase/signal transducer and activator of transcription pathway in canine large cell gastrointestinal lymphoma
• Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
• KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-beta1 axis
• Late-onset relapsing neurotoxicity after Brexucabtagene autoleucel associated with high chimeric antigen receptor T cells in cerebrospinal fluid
• License for a CAR T: Examining patient eligibility
• LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma
• Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature
• Modified SMILE (mSMILE) is active in the treatment of pediatric Epstein-Barr virus-associated natural killer/T-cell lymphoma: a single center experience, case series
• Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy
• Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
• Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine
• Navigating Diagnostic and Therapeutic Challenges in Primary Cutaneous Gamma/Delta T-Cell Lymphoma: A Case Study of Fatal Outcomes Within Two Months
• New and developing first line pharmacotherapies for treating non-hodgkin lymphoma
• New insight into the CNC-bZIP member, NFE2L3, in human diseases
• New therapies for angioimmunoblastic T-cell lymphoma: a comprehensive review and analysis
• Outcome of large B-cell lymphoma patients treated with tafasitamab plus lenalidomide either before or after CAR-T-cells
• PD-L1(+) macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy
• Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial
• Primary intestinal T-cell and natural killer-cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China
• Recurrence of an erythrodermic mycosis fungoides as a biologically indolent anaplastic large T-cell lymphoma initially misdiagnosed as being of donor origin
• Reply to: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study"
• Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma
• Sequential treatment with valemetostat and conventional anti-cancer drugs for refractory aggressive adult T-cell leukemia/lymphoma: A case report
• Single nucleotide polymorphism profiles of canine T-cell and null-cell lymphomas
• Single-cell RNA and T-cell receptor sequencing unveil mycosis fungoides heterogeneity and a possible gene signature
• Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes
• Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms
• Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo
• Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation
• T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers
• T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era
• Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial
• terraFlow, a high-parameter analysis tool, reveals T cell exhaustion and dysfunctional cytokine production in classical Hodgkin's lymphoma
• The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia
• The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain
• The K9 lymphoma assay allows a genetic subgrouping of canine lymphomas with improved risk classification
• The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies
• Time-dependent change of T cell receptor clonality: From large plaque parapsoriasis to early mycosis fungoides
• Towards personalized and rational use of immunoglobulins amid expanding indications and shortages
• Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
• Transition From Epstein-Barr Virus (EBV)-Positive Rectal Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma in the Lung
• Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry
• Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy
• Tumor-derived RHOA mutants interact with effectors in the GDP-bound state
• Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
• Unique presentation of T-cell/histiocyte-rich large B cell lymphoma complicated with hemophagocytic lymphohistiocytosis: Case report and review of the literature
• Waldenstrom macroglobulinemia: a challenging case treated with anti-CD19 CAR-T cell therapy